Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (Q6085905)
From MaRDI portal
scientific article; zbMATH DE number 7776633
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information |
scientific article; zbMATH DE number 7776633 |
Statements
Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information (English)
0 references
12 December 2023
0 references
cancer phase I clinical trial
0 references
drug combination
0 references
escalation with overdose control
0 references
maximum tolerated dose curve
0 references
quasi-continuous toxicity response
0 references
0 references
0 references
